£ £ brief introduction
£ £ 1.the project scale and its contents:establishing 10£¬000 mu of a man-made alstonia planting base
£ £ total investment:5.14million rmb
£ £ 2.project site:simaoprefecture

£ £ investment in need
£ £ 1.foreign investment proportion and its equity ration:1.84 million rmb£¬36%
£ £ 2.investment model:capital introduction
£ £ 3.cooperation model joint-venture£¬cooperation

£ £ market analysis and prediction
£ £ the leaf of alstonia trees is a traditional drug of dai people in china£¬the extracts of alstonia leaves have good effects of anti-cough£¬anti-sputum and anti-inflammation.
£ £ 'dentaiye' series of the south sky pharma.co.ltd are pharmaceutical preparations of the extracts of alstonia leaves£¬it has got a good sales in the market of yunnan province and built a famous drug brand in yunnan.now the gmp production base of south sky pharma will be finished soon£¬the sustained release dosage form of alstonia leaf is being developed£¬the dentaiye series will soon be sold in the whole market of china.the raw material is in short.
£ £ chiniese traditional medicinal plants will be administered by gap in china soon.

£ £ benefit estimation
£ £ 1.duration of profit return:2 years
£ £ 2.estimated profits:116.7 kg of dry leaves to be produced after 2 year planting£¬annual production value is 3 million rmb with 600£¬000 rmb net profit annually.333.3kg of dry leaves per mu to be produced in the 5 year with an annual production value of 10 million rmb.

£ £ preparations done
£ £ small-scale man-made planting has been successfully demonstrated£¬feasibility study is carried out.

£ £ undertaker
£ £ unit to contact: south sky pharma co.ltd£¬simao£®yunnan£¬china.
£ £ address:12 longwangjing road£¬simao£¬665000£¬yunnan£¬china.
£ £ liaison:mr.bao.liu
£ £ tel:0879-1123832 mobile:13828793126
£ £ fax:0879-2122637 email:smntzy@vip.sina.com